Trial intelligence / Profile preview

Long-term oral ferrous sulphate in women with iron deficiency anaemia

2006-005407-33Phase 4Terminated

Sponsor
King's College London
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ferrous sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by King's College London. Primary endpoints: Plasma F2-isoprostanes and Serum non-transferrin-bound iron. Started Oct 2006; status: terminated.

02

Drugs

ferrous sulfate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on 2006-005407-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005407-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call